Literature DB >> 1607889

Fluorescent probe analysis of muscle plasmalemma in Duchenne's progressive muscular dystrophy.

I M Niebrój-Dobosz1.   

Abstract

The relationship between fluorescence intensity and binding of 1-anilino-naphthalene-8-sulphonate (ANS) to muscle plasmalemma in patients with Duchenne's muscular dystrophy (DD) and controls was studied. The fluorescence of ANS was markedly enhanced in DD as compared with controls. The magnitude of this enhancement was increased by monovalent and divalent cations; treatment of DD plasmalemma with trypsin caused an opposite effect. Treatment with phospholipase A and C altered the ANS fluorescence in DD and controls equally. These findings may indicate an increase of the hydrophobic character in the apolar-polar interface of DD plasmalemma. The relationship of these changes to a lack of dystrophin in DD remains to be established.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1607889     DOI: 10.1007/bf00810350

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  Some structural properties of excitable membranes labelled by fluorescent probes.

Authors:  M Kasai; T R. Podleski; J -P. Changeux
Journal:  FEBS Lett       Date:  1970-03-16       Impact factor: 4.124

2.  Sarcoplasmic reticulum. 8. Use of 8-anilino-1-naphthalene sulfonate as conformational probe on biological membranes.

Authors:  J Vanderkooi; A Martonosi
Journal:  Arch Biochem Biophys       Date:  1969-08       Impact factor: 4.013

3.  The effect of phospholipase A upon the interaction of I-anilinonaphthalene-8-sulfonate with erythrocyte membranes.

Authors:  E Weidekamm; D F Wallach; H Fischer
Journal:  Biochim Biophys Acta       Date:  1971-09-14

4.  The study of lipid-protein interactions in membranes by fluorescent probes.

Authors:  D F Wallach; E Ferber; D Selin; E Weidekamm; H Fischer
Journal:  Biochim Biophys Acta       Date:  1970-03-17

5.  Interaction of fluorescent probes with membranes. I. Effect of ions on erythrocyte membranes.

Authors:  B Rubalcava; D Martínez de Muñoz; C Gitler
Journal:  Biochemistry       Date:  1969-07       Impact factor: 3.162

6.  Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface.

Authors:  E Bonilla; C E Samitt; A F Miranda; A P Hays; G Salviati; S DiMauro; L M Kunkel; E P Hoffman; L P Rowland
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

7.  Freeze fracture studies of muscle plasma membrane in human muscular dystrophy.

Authors:  D L Schotland; E Bonilla; Y Wakayama
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

8.  Distribution of freeze-fracture particle sizes in Duchenne muscle plasma membrane.

Authors:  K H Fischbeck; E Bonilla; D L Schotland
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

9.  The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle.

Authors:  E E Zubrzycka-Gaarn; D E Bulman; G Karpati; A H Burghes; B Belfall; H J Klamut; J Talbot; R S Hodges; P N Ray; R G Worton
Journal:  Nature       Date:  1988-06-02       Impact factor: 49.962

10.  Characterization of partially purified heart sarcolemmal Na+-K+-stimulated ATPase.

Authors:  P V Sulakhe; D B McNamara; N S Dhalla
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.